HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

Clinical trial NCT06001385 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06001385
Sponsor: Center for International Blood and Marrow Transplant Research
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Acute Leukemia Myelodysplastic Syndromes Chronic Myeloid Leukemia Chronic Lymphocytic Leukemia Myeloproliferative Neoplasm Lymphoma Chronic Myelomonocytic Leukemia Pro-Lymphocytic Leukemia Myelofibrosis

Start date: 2023-12-08
Primary completion: 2026-12-24
Enrollment: 313

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.